Results 41 to 50 of about 106,721 (360)
Pembrolizumab Induced Sclerosing Cholangitis: Why You Need a Liver Biopsy
Case Reports in Oncology, 2023 The advent of checkpoint inhibitor immunotherapy has rapidly changed the landscape of the management of cancers. However, its use has also been associated with the rise of immunotherapy-related adverse effects (irAEs).
Ian Liang +2 more
doaj +1 more source
Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease [PDF]
, 2016 OBJECTIVES:Autoimmune liver disease is reported in up to 7.8% of children with inflammatory bowel disease. A distinct inflammatory bowel disease phenotype has been suggested in adults and in small pediatric cohorts.
Alexopoulou +31 more
core +1 more source
Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up
BMJ Open Gastroenterology, 2020 Nivolumab is an immune checkpoint inhibitor used to treat multiple solid-organ malignancies. While many of its immune-related adverse events are well established, nivolumab-induced sclerosing cholangitis remains poorly characterised, with no defined ...
Wanyuan Cui +4 more
doaj +1 more source
Journal of Translational Autoimmunity, 2021 Takayasu arteritis and primary sclerosing cholangitis are two rare disorders. The pathogenesis of Takayasu arteritis involves immune-mediated mechanisms, and corticosteroids represent the mainstay for treatment.
Giacomo Mulinacci +4 more
doaj +1 more source
The incidence of portal vein thrombosis at liver transplantation [PDF]
, 1992 The incidence of portal vein thrombosis was examined in 885 patients who received orthotopic liver transplantations for various end‐stage liver diseases between 1989 and 1990. The thrombosis was classified into four grades.
Iwatsuki, S +3 more
core +1 more source
Rapid Progression of Primary Sclerosing Cholangitis Complicated with Ulcerative Colitis
Case Reports in Gastrointestinal Medicine, 2015 Primary sclerosing cholangitis is a cholestatic condition with unknown etiology and long-standing, progressive course, leading to cirrhosis and requiring orthotropic liver transplant. In approximately 80%, primary sclerosing cholangitis is accompanied by
Piotr Pardak +2 more
doaj +1 more source
Case Reports in Gastroenterology, 2022 A 19-year-old man visited our hospital because of diarrhea and blood and liver dysfunction. Magnetic and endoscopic retrograde cholangiography revealed diffuse narrowing of the common biliary tract and intrahepatic biliary tract.
Jin Imai +8 more
doaj +1 more source
Primary sclerosing cholangitis [PDF]
Journal of Gastroenterology and Hepatology, 2006 Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology characterised by inflammation and fibrosis of the biliary tree. The mean age at diagnosis is 40 years and men are affected twice as often as women. There is a reported annual incidence of PSC of 0.9-1.31/100,000 and point prevalence of 8.5-13.6/100,000. The
C E, Eapen, I C, Roberts-Thomson
openaire +7 more sources
Primary Sclerosing Cholangitis and Sarcoidosis. Case Report and Review of the Literature
Canadian Journal of Gastroenterology, 1990 A 43-year-old man with longstanding ulcerative colitis developed primary sclerosing cholangitis established by cholangiography and liver biopsy. Within one year of the diagnosis of primary sclerosing cholangitis, pulmonary sarcoidosis developed, proven ...
Gerry N Schep, Linda J Scully
doaj +1 more source
Pediatrics and Neonatology, 2019 Background: Current knowledge on the clinical features and natural history of childhood primary sclerosing cholangitis – inflammatory bowel disease in Asia is limited.
Way Seah Lee +8 more
doaj +1 more source